Hostname: page-component-5447f9dfdb-g96hj Total loading time: 0 Render date: 2025-07-30T14:38:36.530Z Has data issue: false hasContentIssue false
  • English
  • Français

Resistance to Penicillin and Erythromycin in Viridans Streptococcal Bloodstream Isolates From Cancer and Non-Cancer Patients Within 10 Years

Published online by Cambridge University Press:  02 January 2015

Adriana Ondrusova ,
Anne Liskova ,
Joseph Miklosko ,
Roberta Babela  and
Vladimir Krcmery
Adriana Ondrusova
Affiliation:
School of Public Health, University of TrnavaTrnava, Slovak Republic
Anne Liskova
Affiliation:
Department of Microbiology, Hospital of NitraNitra, Slovak Republic
Joseph Miklosko
Affiliation:
School of Public Health, University of TrnavaTrnava, Slovak Republic
Roberta Babela
Affiliation:
School of Public Health, University of TrnavaTrnava, Slovak Republic and, St. Elizabeth and National Cancer InstitutesBratislava, Slovak Republic
Vladimir Krcmery
Affiliation:
St. Elizabeth and National Cancer InstitutesBratislava, Slovak Republic
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 25 , Issue 5 , May 2004 , pp. 365 - 367
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2004

References

1.Krcmery, V, et al.Increasing resistance to penicillin in viridans streptococci. Lancet 1995;324:1133.Google Scholar
2.Spanik, V, Krcmery, V Jr, et al.Penicillin-resistant viridans streptococcal bacteremia in cancer patients after introduction of V-PNC into prophylaxis. Scand J Infect Dis 1997;39:123–129.Google Scholar
3.Kern, WV, Hay, B, Kern, P, Marre, R, Arnold, R. A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis. Antmicrob Agents Chemother 1994;38:465–472.Google Scholar
4.Bryskier, A. Viridans group streptococci: a reservoir of resistant bacteria in oral cavities. Clin Microbiol Infect 2002;8:65–69.Google Scholar
5.King, A, Bathgate, T, Phillips, I. Erythromycin susceptibility of viridans streptococci from normal throat flora of patients treated with azithromycin or clarithromycin. Clin Microbiol Infect 2002;8:85–92.Google Scholar
6.Johnson, AP, Warner, M, Broughton, K, et al.Antibiotic susceptibility of streptococci and related genera causing endocarditis: analysis of UK reference laboratory referrals, January 1996 to March 2000. BMJ 2001;322:395–396.Google Scholar
7.Jacobs, JA, Stobberingh, EE. In vitro antimicrobial susceptibility of the S. milleri group (Streptococcus anginosus. Streptococcus constellates and Streptococcus intermedins). J Antimicrob Chemother 1996;37:371–375.Google Scholar
8.Banter, C, Conigia, LF, Relloso, S, et al.Species belonging to the Streptococcus milleri group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens. J Clin Microbiol 1996;34:2020–2022.CrossRefGoogle Scholar
9.Gomez-Garces, JL, Alos, J, Cogollos, R. Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group. Diagn Microbiol Infect Dis 1994;19:67–73.CrossRefGoogle ScholarPubMed
10.Arpin, C, Canron, MH, Manglen, J. Incidence of mefA and mefE gene in viridans group streptococci. Antimicrob Agents Chemother 1999;43:2335–2336.Google Scholar
11.Potgieter, E, Cormichael, M, Koornhof, H, Charkley, LJ. In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur J Clin Microbiol Infect Dis 1992;11:543–546.Google Scholar
12.Doern, GV, Ferraro, MJ, Brueggemann, AB, Ruoff, KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996;40:891–894.CrossRefGoogle ScholarPubMed
13.De Azavedo, JCS, Trpeski, L, Pong-Porter, S, Matsumura, S. The Canadian bacterial surveillance network and low DE in vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans streptococci from across Canada. Antimicrob Agents Chemother 1999;43:2299–2301.Google Scholar
14.Harnicarova, A, Streharova, A, Mitterpachova, A, et al.Nosocomial Infections. Trnava, Slovak Republic: University of Trnava; 2002:88.Google Scholar